Literature DB >> 22865584

Basal state hyperinsulinemia in healthy normoglycemic adults heralds dysglycemia after more than two decades of follow up.

R Dankner1, A Chetrit, M H Shanik, I Raz, J Roth.   

Abstract

BACKGROUND: In a preliminary report, we found an association between hyperinsulinemia in the basal (fasting) state and the development of diabetes.
OBJECTIVES: The current analysis further explored the long term link between basal hyperinsulinemia and conversion to dysglycemia.
METHODS: This is a prospective study with up to 24 years of follow-up of 515 normoglycemic individuals (mean age at follow up = 70.3 ± 7.0; range 58-94) of an Israeli cohort. Fasting glucose and insulin were measured, and dysglycemia was defined as fasting glucose > 100 mg/dL.
RESULTS: At the end of the follow-up period, almost half had progressed to dysglycemia. Male sex and elevated baseline levels of basal insulin, body mass index, blood glucose and blood pressure each favoured progression to dysglycemia over the subsequent two decades. A multivariate logistic regression model identified basal hyperinsulinemia as the strongest predictor for progression to dysglycemia (odds ratio = 1.79; 95% confidence interval 1.12-2.88), while controlling for ethnicity, blood pressure, fasting glucose, male sex, body mass index and age.
CONCLUSIONS: Basal hyperinsulinemia in normoglycemic adults constitutes an independent risk factor for metabolic deterioration to dysglycemia over adulthood, and may help to identify apparently healthy subjects at increased risk for diabetes.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22865584     DOI: 10.1002/dmrr.2322

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  10 in total

1.  Diabetic microcirculatory disturbances and pathologic erythropoiesis are provoked by deposition of amyloid-forming amylin in red blood cells and capillaries.

Authors:  Nirmal Verma; Miao Liu; Han Ly; Analia Loria; Kenneth S Campbell; Heather Bush; Philip A Kern; Pedro A Jose; Heinrich Taegtmeyer; Donald M Bers; Sanda Despa; Larry B Goldstein; Andrew J Murray; Florin Despa
Journal:  Kidney Int       Date:  2019-09-05       Impact factor: 10.612

Review 2.  Physiological Systems in Promoting Frailty.

Authors:  Laís R Perazza; Holly M Brown-Borg; LaDora V Thompson
Journal:  Compr Physiol       Date:  2022-04-26       Impact factor: 8.915

Review 3.  Hyperinsulinemia in Obesity, Inflammation, and Cancer.

Authors:  Anni M Y Zhang; Elizabeth A Wellberg; Janel L Kopp; James D Johnson
Journal:  Diabetes Metab J       Date:  2021-03-29       Impact factor: 5.893

4.  Human and mouse muscle transcriptomic analyses identify insulin receptor mRNA downregulation in hyperinsulinemia-associated insulin resistance.

Authors:  Haoning Howard Cen; Bahira Hussein; José Diego Botezelli; Su Wang; Jiashuo Aaron Zhang; Nilou Noursadeghi; Niels Jessen; Brian Rodrigues; James A Timmons; James D Johnson
Journal:  FASEB J       Date:  2022-01       Impact factor: 5.834

5.  Hyperinsulinemia Enhances Hepatic Expression of the Fatty Acid Transporter Cd36 and Provokes Hepatosteatosis and Hepatic Insulin Resistance.

Authors:  Pär Steneberg; Alexandros G Sykaras; Fredrik Backlund; Jurate Straseviciene; Ingegerd Söderström; Helena Edlund
Journal:  J Biol Chem       Date:  2015-06-17       Impact factor: 5.157

Review 6.  Modeling type 2 diabetes in rats using high fat diet and streptozotocin.

Authors:  Søs Skovsø
Journal:  J Diabetes Investig       Date:  2014-05-19       Impact factor: 4.232

7.  Disease or not, aging is easily treatable.

Authors:  Mikhail V Blagosklonny
Journal:  Aging (Albany NY)       Date:  2018-11-17       Impact factor: 5.682

8.  Mitotic regulators and the SHP2-MAPK pathway promote IR endocytosis and feedback regulation of insulin signaling.

Authors:  Eunhee Choi; Sotaro Kikuchi; Haishan Gao; Karolina Brodzik; Ibrahim Nassour; Adam Yopp; Amit G Singal; Hao Zhu; Hongtao Yu
Journal:  Nat Commun       Date:  2019-04-01       Impact factor: 14.919

9.  Assessment of Insulin Resistance in Subjects with Normal Glucose Tolerance, Hyperinsulinemia with Normal Blood Glucose Tolerance, Impaired Glucose Tolerance, and Newly Diagnosed Type 2 Diabetes (Prediabetes Insulin Resistance Research).

Authors:  Guang Yang; Chunlin Li; Yanping Gong; Fusheng Fang; Hui Tian; Jian Li; Xiaoling Cheng
Journal:  J Diabetes Res       Date:  2015-12-07       Impact factor: 4.011

10.  Pancreatic and gut hormones as predictors of new-onset prediabetes after non-necrotising acute pancreatitis: a prospective longitudinal cohort study.

Authors:  Sakina H Bharmal; Wandia Kimita; Juyeon Ko; Maxim S Petrov
Journal:  Endocr Connect       Date:  2021-06-29       Impact factor: 3.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.